GlassScriptPhysician profile
Norma A Lantzsch
NPI 1174735153
$1,708.71
in general payments reported to CMS, 2019-2025
11 companies · $231 in 2025
The $231 reported for 2025 was more than what 79% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,205 · 2022: $12.11 · 2023: $113 · 2024: $148 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284 · Gift: $113 · Entertainment: $94.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.88 |
| Gift | $112.99 |
| Entertainment | $94.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $602.50 | 2021 | |
| Dentsply Sirona INC | $602.50 | 2021 | |
| Ultradent Products INC | $112.99 | 2023 | Opalescence |
| Centrix INC | $97.85 | 2025 | |
| Keystone Dental INC. | $94.73 | 2025 | |
| Ivoclar Vivadent, INC. | $73.30 | 2024 | |
| Pulpdent Corporation | $57.84 | 2024 | |
| Philips North America LLC | $20.42 | 2025 | Oral Health Care Undivided |
| Zest Holdings, LLC | $17.78 | 2025 | |
| Premier Dental Products Company | $16.69 | 2024 | Compcore |
| Kerr Corporation | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Lantzsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.